Werner Schröder

Title: Werner Schröder: Innovator in Monoclonal Antibody Development

Introduction

Werner Schröder is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical diagnostics and therapeutic applications.

Latest Patents

One of his key patents is for a monoclonal antibody and assay for detecting PIIINP. This invention relates to monoclonal antibodies that bind to the N-terminal procollagen (III) propeptide (PIIINP) molecule. PIIINP is a proteolytic fragment that results from the specific cleavage of procollagen (III) by N-proteinase after exocytosis. The assay utilizing these antibodies is crucial for various diagnostic purposes.

Career Highlights

Throughout his career, Werner Schröder has worked with prominent companies in the healthcare sector. Notably, he has been associated with Siemens Healthcare Diagnostics GmbH and Aicuris GmbH & Co. KG. His experience in these organizations has allowed him to contribute to advancements in medical technology and diagnostics.

Collaborations

Werner has collaborated with several professionals in his field, including Elmar Reinhold Burchardt and Werner Kroll. These collaborations have fostered innovation and development in the biotechnology sector.

Conclusion

Werner Schröder's contributions to monoclonal antibody research and development highlight his role as an influential inventor in the biotechnology field. His work continues to impact medical diagnostics and therapeutic strategies.